Biotech firm moving headquarters to SalemBy ADAM SWIFT
Union Leader correspondent
April 30. 2014 8:13PM
SALEM — Foxx Life Sciences provides the kinds of products that biotech, pharmaceutical, and research companies and universities need to succeed.
The company, which purchased the assets of Roush Life Sciences at the end of last year and began doing business as Foxx Life Sciences on Jan. 1, recently signed a lease to move its world headquarters to 6 Delaware Drive.
"We basically provide the tools other companies need to help make their business grow," said company President and CEO Thomas Taylor. Foxx makes filtration and fluid management products for the research, biotech, and pharmaceutical markets.
Among the wide range of disposable research products the company develops and markets are flasks and vented flasks, heavy-duty vacuum bottles, and media bottles.
The company's sales and marketing staff have been operating out of Salem, but with the new Delaware Drive location, Taylor said the company will now be able to bring all its operations, including manufacturing, under one roof.
Sales marketing and engineering are currently at Industrial Way in Salem. Right now, Foxx outsources its manufacturing, but the company will be able to manufacture at the Delaware Drive site, which it plans to begin moving into in June.
"With over 40 percent growth in 2013, we needed a new and much larger facility that was located in southern New Hampshire and had the ability to show well with biotech and pharma customers," Taylor said.
With its location close to Boston, yet in New Hampshire, Taylor said Salem is an ideal location to take advantage of the large medical device, research, and biotech community in Boston and the lower cost of doing business in New Hampshire.
"I live in Windham, so I'm a big fan of doing business in New Hampshire," Taylor said.
Currently, Foxx Life Sciences has 18 full- and part-time employees, but Taylor said the company is growing and that the new 18,302-square-foot leased space will give Foxx the room it needs to expand.
Taylor said one of his goals is also to see the medical device industry grow beyond its focus in the immediate Boston area throughout New England.
Taylor was the president of Roush Life Sciences for five years before acquiring the assets of that company last year. Before joining Roush in 2008, he was the president of Nypro Life Sciences, a division of Nypro, Inc., a billion-dollar global manufacturer of custom plastics.
The acquisition of Roush Life Sciences and the establishment of Foxx Life Sciences has had a definite focus on making the most of New Hampshire business and its assets.
As Taylor has pulled together the new company and the subsequent lease of the new space in Salem, he said it has been with the help of several New Hampshire business. Bank of America in New Hampshire helped Taylor pull together the capital needed to help the business grow while the century-old Manchester-based McLane Law Firm assisted with the acquisition of Roush Life Sciences.
And Chris Healey, an associate in CBRE/New England's Manchester office, represented Foxx in the lease of the space at 6 Delaware Drive.
"We worked together closely to understand their specific needs and came up with a real estate solution that properly matched their situation," Healey said. "We wish Foxx Life Sciences well as they take on the next stage in their corporate growth."
Taylor said an open house for the new headquarters is planned for late summer or early fall.